Furthermore, in advanced‐stage cancers, p‐values of CA19‐9 + CEA with anti‐FIRΔexon2 Abs (p < 0.0001) were higher than those of CA19‐9 (Figure 5E). The gene discussed is CEACAM5; the disease is cancer.